A bombesin-like neuropeptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Neuromedin C (trifluoroacetate salt)

Item No. 24706

Technical Information
Formal Name
7-L-histidine-5-14-bombesin
Synonyms
  • GRP(18-27)
  • NMC
Molecular Formula
C50H73N17O11S • XCF3COOH
Formula Weight
Purity
≥95%
A lyophilized powder
Water: 1 mg/ml
SMILES
NC([C@@H](NC([C@H](CC(C)C)NC([C@@H](NC(CNC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(N)=O)NC(CN[H])=O)=O)CC1=CN=CN1)=O)CC2=CNC3=C2C=CC=C3)=O)C)=O)=O)=O)CC4=CN=CN4)=O)=O)CCSC)=O.FC(F)(C(O)=O)F
InChi Code
InChI=1S/C50H73N17O11S.C2HF3O2/c1-25(2)13-34(46(74)63-33(43(53)71)11-12-79-6)64-47(75)36(15-29-20-54-23-58-29)62-41(70)22-57-50(78)42(26(3)4)67-44(72)27(5)60-45(73)35(14-28-19-56-32-10-8-7-9-31(28)32)65-48(76)37(16-30-21-55-24-59-30)66-49(77)38(17-39(52)68)61-40(69)18-51;3-2(4,5)1(6)7/h7-10,19-21,23-27,33-38,42,56H,11-18,22,51H2,1-6H3,(H2,52,68)(H2,53,71)(H,54,58)(H,55,59)(H,57,78)(H,60,73)(H,61,69)(H,62,70)(H,63,74)(H,64,75)(H,65,76)(H,66,77)(H,67,72);(H,6,7)/t27-,33-,34-,35-,36-,37-,38-,42-;/m0./s1
InChi Key
YTDVZQVYMKGASO-PQMUPELQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Neuromedin C is a bombesin-like neuropeptide that stimulates uterine smooth muscle contraction and the release of gastrin (Item No. 24457), somatostatin, and amylase in rats.1,2 Neuromedin C is a truncated form of gastrin-releasing peptide (GRP; Item Nos. 24415 | 24455) corresponding to the GRP amino acids 18-27. It inhibits GRP and bombesin (Item No. 24151) binding to rat pancreatic membranes (IC50s = 0.4 and 2.2 nM, respectively), which can be reduced by sodium chloride and guanylyl imidodiphosphate (Item No. 16880).2 Neuromedin C induces scratching and mast cell degranulation in mice when administered intradermally at doses ranging from 1 to 300 nmol/site, which is inhibited by the BB2 bombesin receptor agonist RC-3095 and reduced in mast cell-deficient mice.3 Neuromedin C (3.2 nmol/kg, i.p.) reduces rat glucose consumption by approximately 50% for up to one hour.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Madaus, S., Schusdziarra, V., Seufferlein, T., et alEffect of gastrin-releasing peptide (GRP1-27), neuromedin-C (GRP18-27), and neuromedin-B on gastrin and somatostatin secretion from the rat stomach. Z. Gastroenterol. 27(9), 449-454 (1989).

    2. Sekar, M.C., Uemura, N., Coy, D.H., et alBombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides. Biochem J. 280(Pt. 1), 163-169 (1991).

    3. Andoh, T., Kuwazono, T., Lee, J.-B., et alGastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. Peptides 32(10), 2098-2103 (2011).

    4. Ladenheim, E.E., Taylor, J.E., Coy, D.H., et alBlockade of feeding inhibition by neuromedin B using a selective receptor antagonist. Eur. J. Pharmacol. 271(1), R7-R9 (1994).